DE69626539D1 - topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen - Google Patents

topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen

Info

Publication number
DE69626539D1
DE69626539D1 DE69626539T DE69626539T DE69626539D1 DE 69626539 D1 DE69626539 D1 DE 69626539D1 DE 69626539 T DE69626539 T DE 69626539T DE 69626539 T DE69626539 T DE 69626539T DE 69626539 D1 DE69626539 D1 DE 69626539D1
Authority
DE
Germany
Prior art keywords
vitamin
treatment
topical use
eye diseases
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626539T
Other languages
English (en)
Other versions
DE69626539T2 (de
Inventor
Kiyoshi Kita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69626539D1 publication Critical patent/DE69626539D1/de
Publication of DE69626539T2 publication Critical patent/DE69626539T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
DE69626539T 1995-11-20 1996-04-22 topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen Expired - Fee Related DE69626539T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP33558795 1995-11-20
JP33558795 1995-11-20
JP34992995 1995-12-13
JP34992995 1995-12-13
JP35170895 1995-12-18
JP35170895 1995-12-18
PCT/JP1996/001082 WO1997018817A1 (fr) 1995-11-20 1996-04-22 Preparation externe contenant de la vitamine d ou de la vitamine k

Publications (2)

Publication Number Publication Date
DE69626539D1 true DE69626539D1 (de) 2003-04-10
DE69626539T2 DE69626539T2 (de) 2004-04-08

Family

ID=27340732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626539T Expired - Fee Related DE69626539T2 (de) 1995-11-20 1996-04-22 topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen

Country Status (6)

Country Link
US (1) US6162801A (de)
EP (1) EP0862916B1 (de)
JP (1) JP3738450B2 (de)
AU (1) AU5347696A (de)
DE (1) DE69626539T2 (de)
WO (1) WO1997018817A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10316574A (ja) * 1997-05-16 1998-12-02 Santen Pharmaceut Co Ltd ドライアイ治療剤
WO1998053806A1 (fr) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Compositions medicinales a administration topique renfermant les vitamines d et les vitamines k
US6187331B1 (en) 1997-06-10 2001-02-13 New Vision Co., Ltd. Composition for prophylaxis and/or treatment of dry syndrome comprising vitamin D
WO1998056388A1 (fr) * 1997-06-10 1998-12-17 New Vision Co., Ltd. Agents prophylactiques et/ou remedes contenant de la vitamine d pour prevenir et/ou traiter le xerosis conjonctival/corneen
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
FR2768340B1 (fr) * 1997-09-18 2000-05-26 Rocher Yves Biolog Vegetale Nouvelle utilisation de l'ergosterol et de ses composes apparentes, en cosmetique
US6420352B1 (en) * 2000-07-19 2002-07-16 W. Roy Knowles Hair loss prevention
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
US20030211043A1 (en) * 2001-09-28 2003-11-13 Korb Donald R. Eye treatment
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US7435725B2 (en) 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US20030105031A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Methods for the treatment of skin disorders
US6753325B2 (en) * 2001-11-06 2004-06-22 The Quigley Corporation Composition and method for prevention, reduction and treatment of radiation dermatitis
US20070184089A1 (en) * 2002-07-15 2007-08-09 Alcon, Inc. Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
DK1521573T3 (da) * 2002-07-15 2008-03-25 Alcon Inc Ikke-polymere, lipofile, farmaceutiske implantatsammensætninger til intrakulær anvendelse
US7083813B2 (en) 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
EP1458678A1 (de) * 2002-11-18 2004-09-22 Teva Pharmaceutical Industries Limited Kristallisationsverfahren zur reinigung von calcipotriene
JP2004262777A (ja) * 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
US20040186082A1 (en) * 2003-03-20 2004-09-23 Hartman Raymond A. Enhanced phototherapy for the treatment of cancer and autoimmune disease
JP5416688B2 (ja) * 2003-12-26 2014-02-12 ロート製薬株式会社 粘度低下が防止された組成物
US20050163873A1 (en) * 2004-01-14 2005-07-28 Robert Ritch Methods and formulations for treating glaucoma
US9539202B2 (en) * 2006-04-28 2017-01-10 Universidad Complutense De Madrid Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
RU2452488C2 (ru) * 2006-08-29 2012-06-10 Тева Фармасьютикал Индастриес Лтд. Фармацевтические композиции, содержащие витамин группы d и кортикостероид
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
WO2009002790A2 (en) * 2007-06-26 2008-12-31 Bausch & Lomb Incorporated Compositions and methods for treating, reducing, ameliorating, alleviating, or preventing dry eye
KR101394538B1 (ko) * 2012-02-29 2014-05-13 연세대학교 산학협력단 Ｔｇｆｂｉ 유전자 변이 각막이상증의 예방 또는 치료용 약제학적 조성물 및 그의 스크리닝 방법
EP2878295A4 (de) * 2012-07-24 2015-12-23 J Oil Mills Inc Zusammensetzung
WO2014208709A1 (ja) 2013-06-28 2014-12-31 学校法人 慶應義塾 マイボーム腺機能不全の処置剤
EP3890746A4 (de) * 2018-12-06 2022-08-10 Lipicare Life Sciences Ltd. Vitamin-d-mikroemulsionen und deren verwendungen
WO2021148845A1 (en) * 2020-01-23 2021-07-29 Visufarma S.P.A. Ophthalmic composition for the treatment of dry eye disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431841A (en) * 1973-01-15 1976-04-14 Evans S C Ophthalmic-nutritional preparations
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
DE3514724A1 (de) * 1985-04-24 1986-10-30 Albin F. Dr. 4200 Oberhausen Jereb Salbe zur verbeugung und behandlung von augen- und hauterkrankungen
JPS63145233A (ja) * 1986-12-09 1988-06-17 Teijin Ltd 白内障治療剤
JP2676049B2 (ja) * 1988-03-30 1997-11-12 サンスター株式会社 皮膚化粧料
US4923699A (en) * 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
JPH02178218A (ja) * 1988-12-27 1990-07-11 Kanebo Ltd タンニング皮膚化粧料
US5254538A (en) * 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
EP0494995A4 (en) * 1989-10-04 1993-03-17 Trustees Of Boston University Method of accelerating wound and ulcer healing and treating periodontal disease
JPH05508655A (ja) * 1990-06-21 1993-12-02 トラスティーズ・オブ・ボストン・ユニバーシティー ビタミンｄ前駆体からなる組成物、それらの類似体およびそれらの用途
JPH05320039A (ja) * 1991-09-20 1993-12-03 Taiyo Kagaku Co Ltd 美白化粧料
AU5018893A (en) * 1992-08-17 1994-03-15 Alcon Laboratories, Inc. Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
US5449668A (en) * 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
GB9409882D0 (en) * 1994-05-18 1994-07-06 Sandoz Ltd Organic compounds
TW422696B (en) * 1995-03-20 2001-02-21 Katsuhiko Mukai Ophthalmic composition containing active vitamin D
WO1998018468A1 (en) * 1996-10-31 1998-05-07 American Home Products Corporation Synergistic composition comprising rapamycin and calcitriol

Also Published As

Publication number Publication date
DE69626539T2 (de) 2004-04-08
WO1997018817A1 (fr) 1997-05-29
EP0862916A4 (de) 2001-01-10
US6162801A (en) 2000-12-19
JP3738450B2 (ja) 2006-01-25
EP0862916A1 (de) 1998-09-09
EP0862916B1 (de) 2003-03-05
AU5347696A (en) 1997-06-11

Similar Documents

Publication Publication Date Title
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69612649T2 (de) Indolinonverbindungen zur behandlung von krankheiten
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69621447T2 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE59806627D1 (de) Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
ATE290866T1 (de) Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten
NO981822L (no) Anvendelse av proteinet GAX for behandling av cancer
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee